NACOGDOCHES COUNTY, Texas (KTRE) - The Lilly Grove Special Utility District has issued a boil water notice due to a leak caused by a fiber optic installation. To ensure the destruction of all harmful ...

Eli Lilly stock (NYSE: LLY) is up 10% this month, a rise driven by strong clinical trial progress. This includes the announcement of positive Phase 3 results in October 2025 for its oral GLP-1 drug, ...

NACOGDOCHES COUNTY, Texas (KTRE) - The Lilly Grove Special Utility District has issued a boil water notice due to a leak caused by a fiber optic installation. The boil water notice effects the nat ...

Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking up wins against placebo and AstraZeneca’s Farxiga to stay on track to seek ...

Just as Adverum Biotechnologies' cash reserves were running dry, Eli Lilly has swooped in to buy the biotech and its phase 3-stage eye disease gene therapy. The prize for Lilly is ixo-vec, an ...

Now four years into a first-in-class FDA approval for certain HR-positive, HER2-negative early breast cancers, Eli Lilly’s Verzenio has proven it can extend patients’ lives in the indication. Verzenio ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Lilly is looking to build four ...

Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose Acquisition aligns Lilly's ...

Oct 23 (Reuters) - Eli Lilly (LLY.N), opens new tab signed an agreement with Cipla (CIPL.NS), opens new tab, allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a separate ...

Lily Allen is so back. The singer-songwriter, known for 2000s hits like “Smile” and “The Fear,” just released her first album in seven years, West End Girl—and she’s not holding back. This not only ...

Oct 13 (Reuters) - South Africa's Aspen Pharmacare (APNJ.J), opens new tab said on Monday it had secured regulatory approval to market Eli Lilly's (LLY.N), opens new tab blockbuster diabetes and ...